Literature DB >> 3994899

Plasma concentrations of melatonin in man following oral absorption of different preparations.

M Aldhous, C Franey, J Wright, J Arendt.   

Abstract

The plasma concentrations of melatonin in man, fasting and fed, were determined after ingestion of three different oral preparations. A dose of 2 mg was given as either a gelatine capsule, a solution in corn oil or as a slow-release pill. Gelatine capsules and the corn oil preparation gave reproducibly timed peak plasma concentrations, 30 to 60 min after ingestion regardless of nutritional status, and plasma melatonin remained at or above endogenous night-time levels for 3-4 h with mean elimination half-lives of 0.54 to 0.67 h. The slow-release preparation usefully extended high plasma melatonin concentrations for 5-7 h after ingestion but the timing of peak concentrations was very dependent on nutritional status. These preparations should be of use in the study of timed melatonin administration in man.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3994899      PMCID: PMC1463812          DOI: 10.1111/j.1365-2125.1985.tb02679.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

1.  Effect of melatonin on the reproductive systems of male and female Syrian hamsters: a diurnal rhythm in sensitivity to melatonin.

Authors:  L Tamarkin; W K Westrom; A I Hamill; B D Goldman
Journal:  Endocrinology       Date:  1976-12       Impact factor: 4.736

2.  Melatonin: clinical pharmacology.

Authors:  A B Lerner; J J Nordlund
Journal:  J Neural Transm Suppl       Date:  1978

Review 3.  The pineal and its hormones in the control of reproduction in mammals.

Authors:  R J Reiter
Journal:  Endocr Rev       Date:  1980       Impact factor: 19.871

4.  STRIPE: an interactive computer program for the analysis of drug pharmacokinetics.

Authors:  A Johnston; R C Woollard
Journal:  J Pharmacol Methods       Date:  1983-05

5.  Direct radioimmunoassay for melatonin in plasma.

Authors:  S Fraser; P Cowen; M Franklin; C Franey; J Arendt
Journal:  Clin Chem       Date:  1983-02       Impact factor: 8.327

6.  Free-running activity rhythms in the rat: entrainment by melatonin.

Authors:  J Redman; S Armstrong; K T Ng
Journal:  Science       Date:  1983-03-04       Impact factor: 47.728

7.  Role of the pineal gland in ovine photoperiodism: regulation of seasonal breeding and negative feedback effects of estradiol upon luteinizing hormone secretion.

Authors:  E L Bittman; F J Karsch; J W Hopkins
Journal:  Endocrinology       Date:  1983-07       Impact factor: 4.736

8.  Antigonadal effects of timed melatonin infusion in pinealectomized male Djungarian hamsters (Phodopus sungorus sungorus): duration is the critical parameter.

Authors:  D S Carter; B D Goldman
Journal:  Endocrinology       Date:  1983-10       Impact factor: 4.736

9.  Melatonin accelerates the reentrainment of the circadian adrenocortical rhythm in inverted illumination cycle.

Authors:  N Murakami; C Hayafuji; Y Sasaki; J Yamazaki; K Takahashi
Journal:  Neuroendocrinology       Date:  1983-05       Impact factor: 4.914

10.  Melatonin can induce early onset of the breeding season in ewes.

Authors:  J Arendt; A M Symons; C A Laud; S J Pryde
Journal:  J Endocrinol       Date:  1983-06       Impact factor: 4.286

  10 in total
  34 in total

1.  Over-the-Counter Agents for the Treatment of Occasional Disturbed Sleep or Transient Insomnia: A Systematic Review of Efficacy and Safety.

Authors:  Larry Culpepper; Mark A Wingertzahn
Journal:  Prim Care Companion CNS Disord       Date:  2015-12-31

2.  Low dose melatonin improves sleep in healthy middle-aged subjects.

Authors:  M E Attenburrow; P J Cowen; A L Sharpley
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

Review 3.  Clinical pharmacokinetics of melatonin: a systematic review.

Authors:  Nathja Groth Harpsøe; Lars Peter Holst Andersen; Ismail Gögenur; Jacob Rosenberg
Journal:  Eur J Clin Pharmacol       Date:  2015-05-27       Impact factor: 2.953

4.  Pharmacokinetics of melatonin in preterm infants.

Authors:  Nazakat M Merchant; Denis V Azzopardi; Ahmed F Hawwa; James C McElnay; Benita Middleton; J Arendt; Tomoki Arichi; Pierre Gressens; A David Edwards
Journal:  Br J Clin Pharmacol       Date:  2013-11       Impact factor: 4.335

5.  Melatonin in children with autism spectrum disorders: endogenous and pharmacokinetic profiles in relation to sleep.

Authors:  Suzanne E Goldman; Karen W Adkins; M Wade Calcutt; Melissa D Carter; Robert L Goodpaster; Lily Wang; Yaping Shi; Helen J Burgess; David L Hachey; Beth A Malow
Journal:  J Autism Dev Disord       Date:  2014-10

6.  A mathematical model of the circadian phase-shifting effects of exogenous melatonin.

Authors:  Emily R Breslow; Andrew J K Phillips; Jean M Huang; Melissa A St Hilaire; Elizabeth B Klerman
Journal:  J Biol Rhythms       Date:  2013-02       Impact factor: 3.182

Review 7.  Optimal dosages for melatonin supplementation therapy in older adults: a systematic review of current literature.

Authors:  Esmée M S Vural; Barbara C van Munster; Sophia E de Rooij
Journal:  Drugs Aging       Date:  2014-06       Impact factor: 3.923

8.  Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection.

Authors:  C Mallo; R Zaĭdan; G Galy; E Vermeulen; J Brun; G Chazot; B Claustrat
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 9.  Physiological and metabolic functions of melatonin.

Authors:  J Barrenetxe; P Delagrange; J A Martínez
Journal:  J Physiol Biochem       Date:  2004-03       Impact factor: 4.158

10.  Melatonin inhibits the proliferation of retinal pigment epithelial (RPE) cells in vitro.

Authors:  H S Yu; V Hernandez; M Haywood; C G Wong
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-05       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.